Back to search results
NCT07563387

taVNS for Speech and Language Recovery in Aphasia

Enrolling by Invitation
NAAges 18–80InterventionalTreatment
University of Florida
~12 participants
Updated 2026-05-04 on ClinicalTrials.gov
What's tested:taVNSsham taVNS

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Adverse events
Measured over 6 months
+1 more outcome measured

Conditions

Aphasia
Apraxia of Speech

Explore related trials

AphasiaApraxic aphoniaStrokeTraumatic Encephalopathy

NCT07563387

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Brooks Rehabilitation Clinical Research Center

    Jacksonville, Floridano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adults between 18-80
Native speakers of English or simultaneous bilinguals
At least 6 months post stroke or TBI
Diagnosed production type aphasia or apraxia of speech

Exclusion

Additional cognitive or neurological impairments (Autism, schizophrenia, seizures, etc)
Language comprehension deficits
Medications that influence key neurotransmitters

What this trial measures

  • Adverse events6 months

    Frequency and severity of adverse events will be monitored and evaluated for severity and impact on attrition.

  • Compliance6 months

    Percentage of the population that remains engaged in the study and completes all stimulation sessions.